EP1702553B1 — Capsule-type medical device
Assigned to Olympus Corp · Expires 2008-10-29 · 18y expired
What this patent protects
A capsule-type medical device (3) suitable for increasing radio wave strength by enhancing efficiency of radio transmission/reception by an antenna. The capsule-type medical device (3) comprises an imaging/illuminating section (21) provided with an illumination optical system and…
USPTO Abstract
A capsule-type medical device (3) suitable for increasing radio wave strength by enhancing efficiency of radio transmission/reception by an antenna. The capsule-type medical device (3) comprises an imaging/illuminating section (21) provided with an illumination optical system and an imaging section that are used as a means for executing a specified function in a subject body, an RF section (23) as a radio means for communicating a signal with the outside of the subject body by radio, the signal being a signal generated by driving the imaging/illuminating section (21) or a signal for controlling the drive of the imaging/illuminating section (21), and an antenna (26) having a pair of antenna elements (26a, 26b) formed in a tubular shape covering the outer circumference of the imaging/illuminating section (21).
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.